Clomipramine increases the incidence and duration of spike-wave discharges in freely moving WAG/Rij rats

被引:5
作者
Zsolt Kovacs [1 ]
Andras Czurko [2 ,3 ]
Kekesi, Katalin A. [2 ,4 ]
Gabor Juhasz [2 ]
机构
[1] Univ W Hungary, Dept Zool, H-9700 Budapest, Hungary
[2] Eotvos Lorand Univ, Lab Prote, H-1117 Budapest, Hungary
[3] Univ Szeged, Inst Med Chem, H-6720 Szeged, Hungary
[4] Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1117 Budapest, Hungary
关键词
Absence epilepsy; Clomipramine; WAG/Rij rats; ABSENCE EPILEPSY; GENERALIZED ABSENCE; RECEPTORS; SEIZURES; MODEL; 5-HT1A; NEUROTRANSMISSION; REDUCTION; 8-OH-DPAT; INHIBIT;
D O I
10.1016/j.eplepsyres.2010.02.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: The noradrenergic and serotonergic system may have a role in modulation of absence seizures. We investigated whether the single injection of monoamine reuptake inhibitor clomipramine has an acute effect on spike-wave discharge (SWD) activity in Wistar Albino Glaxo/Rijswijk (WAG/Rij) rats. Methods: We injected a single dose of 20 or 50 mg/kg clomipramine intraperitoneally into WAG/Rij rats and measured the incidence and duration of SWD episodes for 4 h after injection. The changes in SWDs were compared to the preceding 5-day average control level. Results: The 20 mg/kg clomipramine significantly increased the incidence of SWDs in the first measured hour while the 50 mg/kg dose significantly increased the incidence and duration of SWDs in the whole measured 4-h period. Conclusions: Clomipramine, by acutely elevating synaptic monoamine levels, could exacerbate absence seizures. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 24 条
[1]   Seizure incidence in psychopharmacological clinical trials: An analysis of food and drug administration (FDA) summary basis of approval reports [J].
Alper, Kenneth ;
Schwartz, Kelly A. ;
Kolts, Russell L. ;
Khan, Arif .
BIOLOGICAL PSYCHIATRY, 2007, 62 (04) :345-354
[2]  
BUGE A, 1974, NOUV PRESSE MED, V3, P373
[3]   NORADRENERGIC CONTROL OF THALAMIC OSCILLATION - THE ROLE OF ALPHA-2 RECEPTORS [J].
BUZSAKI, G ;
KENNEDY, B ;
SOLT, VB ;
ZIEGLER, M .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1991, 3 (03) :222-229
[4]   Genetic animal models for absence epilepsy: A review of the WAG/Rij strain of rats [J].
Coenen, AML ;
van Luijtelaar, ELJM .
BEHAVIOR GENETICS, 2003, 33 (06) :635-655
[5]   A serotonin-1A receptor agonist and an N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model [J].
Filakovszky, J ;
Gerber, K ;
Bagdy, G .
NEUROSCIENCE LETTERS, 1999, 261 (1-2) :89-92
[6]   8-OH-DPAT and MK-801 affect epileptic activity independently of vigilance [J].
Filakovszky, J ;
Kantor, S ;
Halasz, P ;
Bagdy, G .
NEUROCHEMISTRY INTERNATIONAL, 2001, 38 (07) :551-556
[7]   The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy [J].
Gerber, K ;
Filakovszky, J ;
Halasz, P ;
Bagdy, G .
BRAIN RESEARCH, 1998, 807 (1-2) :243-245
[8]   Tricyclic antidepressant pharmacology and therapeutic drug interactions updated [J].
Gillman, P. K. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (06) :737-748
[9]   Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy [J].
Graf, M ;
Jakus, R ;
Kantor, S ;
Levay, G ;
Bagdy, G .
NEUROSCIENCE LETTERS, 2004, 359 (1-2) :45-48
[10]   MODULATION OF RAT NEOCORTICAL HIGH-VOLTAGE SPINDLE ACTIVITY BY 5-HT1/5-HT2 RECEPTOR SUBTYPE-SPECIFIC DRUGS [J].
JAKALA, P ;
SIRVIO, J ;
KOIVISTO, E ;
BJORKLUND, M ;
KAUKUA, J ;
RIEKKINEN, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 282 (1-3) :39-55